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Abstract
Since 2011, an international group of health policy experts has been working 
on a value-framework to be used for pharmaceutical policy decisions based on 
multicriteria decision analysis (MCDA). This tool can be easily adapted to a local 
decision-making context through a facilitated workshop format. Several workshops 
have been conducted in emerging markets to test the acceptance and feasibility of 
using MCDA in local decision-making. In China, national policy goals for expand-
ing health-care coverage pressure the provincial governments to implement more 
comprehensive coverage schemes. This chapter demonstrates the adaptation of 
a global value-framework to the local policy environment. In September 2018, 
nine leaders from provincial health insurance bureaus responsible for the urban 
employee basic medical insurance (UEBMI) participated in a 1-day workshop to 
build a consensus on the most important objectives for the health-care reform and 
to translate these into measurable criteria. The participants ranked the criteria by 
importance and MCDA methodology was used for weighing the importance of each 
criterion in the final decision. The model driving this process will be presented and 
discussed by comparing two policy options for health-care reform.
Keywords: China, multicriteria decision analysis, MCDA, insurance policy,  
decision-making, stakeholder engagement, medical savings account
1. Introduction
1.1 Provincial insurance schemes in China
In 1998, the State Council of China issued a decision on establishing the basic 
medical insurance system for urban employees [1].
As a consequence, a universal medical insurance system (UMIS) was designed 
to improve access to medical services and reduce out-of-pocket (OOP) costs for all 
Chinese citizens [2]. By 2014, 97.5% of the population had some form of insur-
ance coverage. The key options are the urban employee basic medical insurance 
(UEBMI), the new rural cooperative medical scheme (NRCMS), or the urban 
resident basic medical insurance (URBMI). The differences are in the type of 
population covered (e.g., in 2014, 283.3 million urban employees, 736 million rural 
citizens, or 314.5 million urban residents), in the annual premium per capita  
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(in 2014, 2841 RMB for UEBMI, 411 RMB for NRCMS, or 409 RMB for URBMI) 
and consequently, the scope of available funds and coverage [2].
All employing units (employers) and their employees in cities and towns are 
intended to participate in the UEBMI. The expenses of basic medical insurance shall 
be shared by employers and employees. The basic system includes the combination 
of social coordination funds and individual medical saving accounts (MSAs).
The basic medical insurance premiums are paid by individual employees with a 
2% payroll tax and by employers with 6% payroll tax. About 30% of the contribu-
tions of employers are paid into the personal MSAs, while the remaining 70% of the 
basic medical insurance premiums are collected as coordination funds. Individual 
MSAs are used for outpatient payment, the coordination funds are used for hospi-
talization and to provide for coverage of some special diseases with high medical 
costs in outpatient departments [3]. The maximum ceiling payment is limited at 
four to six times the average annual wage of local employees. The excess cost can 
be insured by commercial medical insurance or government medical assistance. In 
2010, these basic medical insurance principles were included in the Social Insurance 
Law of the People’s Republic of China [4].
1.2 Why is change needed?
Although all provinces have implemented provincial solutions for the basic medi-
cal insurance for employees, a few shortcomings have been observed over the years. 
These include the risk that the funds in the MSAs are not always used efficiently and 
may not suffice to cover a comprehensive outpatient care. In consequence, patients 
may prefer to use inpatient care facilities, which however, lead to higher overall 
costs [3, 5]. Simply put, individual choices on use of health-care funds are done with 
the short-term individual or family advantage in mind, whereas with pooled HC 
funds, decisions can be made based on overall health outcome of the population, 
and supply cost can be negotiated or managed accordingly. Not every individual 
owner of an MSA has the capability to invest in that HC service, which maximizes 
health outcomes with the available funds, and there is a risk that individual choices 
favor delayed treatments at more advanced stages of disease and to worse outcomes. 
An international study on the efficiency of MSA across different countries (China, 
Singapore, South Africa, and the United States of America) concluded that “the 
available evidence suggests that MSA schemes have generally been inefficient and 
inequitable and have not provided adequate financial protection” [6].
In addition, many healthy people or high-income employees do not use the 
savings in the personal accounts and therefore, they accumulate over time in 
the personal MSAs and are not available for the financing of current health-care 
services [7]. For example, in the Liaoning Province, the recent average proportion 
of health-care funds accumulated in individual accounts reached 40%, resulting 
in almost half of medical insurance funds being accumulated as surplus held in 
the MSAs. The same situation as was observed in Shanghai in 2015, with 40.3% of 
premium surplus accumulated in medical savings accounts [8]. In a model with a 
pooled fund administered across the whole membership, the entire budget could be 
allocated for health-care services across the members as needed. Thus, at any time, 
the money which is not spent by healthy people can be used for the treatment of 
sick people.
In terms of equity, a high variation in scope of coverage is also observed [9]. For 
access to medicines, distorted funding mechanisms create financial barriers for 
access to medicine in China [10, 11]. Research in 2014 on the impact of the UEBMI 
on equity revealed improved equity for inpatient services, but inequity growth for 
outpatient services [12].
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Affordability of medicines, a major part of outpatient care, is also still of 
concern [13]. There is a high regional variability in the scope of coverage and 
reimbursement methods [13]. For example, in some cities, the coverage for phar-
maceuticals lies within the general outpatient coverage scheme; in others a range of 
“regulated diseases” are defined for coverage, whereas in other cities, a secondary 
drug reimbursement lists exist.
Due to these challenges and shortcomings, provincial insurance authorities 
want to improve their insurance policies for UEBMI by raising reimbursement for 
outpatient care services and products. This will in turn improve utilization of all 
available funds to increase the overall efficiency of healthcare.
1.3 A format to facilitate policy decisions
In China, the responsibility for transferring nationally formulated policy objec-
tives into the provinces is decentralized and lies with the provincial administration. 
There are many options on how the provincial policies can be formulated and 
applied. Alignment of the overall central policy is important to ensure consistency 
and equity in health-care access for the Chinese population. However, new policies 
are in the responsibility of the provincial insurance authorities, and therefore, the 
policy decision has to be made in each province under consideration of the national 
policy priorities and the provincial political and health-care context. In such 
complex situations, decision support tools may help the provincial authorities to 
prioritize possible insurance options.
Among the plethora of decision support tools, multiple criteria decision 
analysis (MCDA) was chosen because this method can help to assess multiple, 
and sometimes conflicting, criteria to evaluate alternatives [14–16]. It originates 
from operational research supporting single decision-makers [17] but is increas-
ingly also used to structure decision alternatives, to prognose their consequences, 
and to facilitate dialog on the benefits and harms of decisions in a multistake-
holder context in order to enhance procedural quality in the decision-making 
process [18]. MCDA methods are used across many branches of science and 
policy-making including environmental, infrastructural, and health-care poli-
cies, prioritization, and planning [15, 19, 20].
Next to MCDA, other methods are existing to inform strategic decisions between 
alternative option and much can be learned from the world of business manage-
ment [21]. Some of these lead to increasing complexity such as strategic options 
development and analysis (SODA), a comprehensive cognitive mapping of indi-
vidual stakeholder views. Others, such as a “strengths, weakness, opportunity, and 
threat” (SWOT) analysis, structure the thinking and accumulate facts and data, but 
the interpretation and weighing is left to the decision-makers. Pure deliberation of 
the alternatives in the discussion among decision-makers and experts often lead to 
decisions of low transparency and may lack consistency. Simulating the impact of a 
new policy in a health economic models or trade-off models would limit the factors 
to be considered.
MCDA is an umbrella term for decision support tools which can be used in 
situations like presented here for the Chinese insurance policies, where (1) there 
are one or several clearly stated objectives that stakeholders groups and/or decision-
makers value differently [20], (2) there are several alternative options how to fully 
or partially reach these objectives, and (3) there multiple criteria, which can be 
integrated into a calculable composite measure of the benefit or worth of the vari-
ous alternatives [21]. Among the MCDA methods are the analytic hierarchy process, 
weighed sum and weighed product models, or ranking and simple multiattribute 
rating techniques (SMART) as described below [22, 23].
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A taskforce of the International Society of Pharmacoeconomics and Outcomes 
Research (ISPOR) has described the MCDA process for the use in health-care 
decisions [24, 25]. Generally, the process includes six steps, and is adapted based on 
the specific decision problem, objective, and context. The definition of the decision 
problem is the first step. Subsequently, agreement needs to be reached among the 
stakeholders to determine which criteria are useful to determine the alternative 
option that will best solve the decision problem. If the importance of these defined 
criteria differs, the stakeholders also should agree on the weight (relative impor-
tance) of each criterion in the assessment of the alternative options.
Finally, in the assessment of the alternatives, each criterion is scored separately and 
contributes with the predetermined weight, to the composite score that reflects the 
overall performance of each alternative. As decisions in healthcare often impact a wide 
range of stakeholders, the criteria may also be chosen to accommodate different stake-
holder perspectives [26]. MCDA is being used widely across health-care systems to 
inform decision-making in healthcare, including benefit-risk assessment of medicines, 
formulary listings, purchasing, or reimbursement decisions [25, 27–29]. MCDA has 
specifically been suggested as an evidence-based health technology assessment (HTA) 
tool for evaluating off-patent pharmaceuticals in developing countries [30]. Examples 
for using MCDA in decision-making for off-patent medicines in developing countries 
are emerging in several countries such as China, Thailand, Indonesia, or Egypt [31–34].
A short explanation of MCDA in lay language (English) can be viewed in the 
online material to this book and via the Internet (https://www.youtube.com/
watch?v=7OoKJHvsUbo).
1.4 Policy initiative in China
The objective of this initiative was to collaborate among provincial insurance 
policy leaders in China to create an MCDA tool to evaluate insurance policy options 
across China. This collaborative process was intended to provide a transparent 
prioritization of insurance models to guide provinces in the decision process. A 
secondary objective was to adapt a globally validated MCDA in a local environment 
to address a specific decision problem.
2. Process for adaptation of a global format
MCDA is a method to support decision-making, while allowing for adaptation 
to a specific decision problem. The methodology, framework, and process applied 
in the workshop followed a previously developed and validated model (Figure 1) 
[30, 33] for adaptation to a new decision problem and context. Each of the phases 
will be described in detail below.
2.1 Workshop preparation
To achieve broad buy-in and acceptance for the tool, many of the important 
stakeholders should be included. Through participation in an interactive workshop, 
individual stakeholders will be able to see exactly how the tool was developed and 
can contribute their perspective to shape the new tool. In order to limit the work-
shop to less than 1-day preparation prior to the workshop is important. Ideally, 
the definition of the decision problem should occur prior to the workshop. For the 
initiative described here, decision problem was the assessment of health-care policy 
options across China (see Section 1.4).
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2.1.1 Stakeholder engagement
One of the core principles of designing and implementing change is that the 
key stakeholders are considered throughout the process according to their respec-
tive position in the context of the change. The design and implementation of 
the new insurance policies will be the responsibility of the provincial insurance 
authorities under the conditions outlined by the national policy framework. They 
will not only have to be convinced by the new insurance model and its feasibility, 
but they will also have to defend any new design versus the outside stakeholders 
such as provincial policy-makers, provincial urban employers, and provincial 
urban employees, and toward the inside stakeholders who will be charged with 
the implementation.
In this initiative, the analysis started by listing all impacted stakeholders who 
hold influence over the proposed change in program. Each of the stakeholders was 
rated by their level of interest in the insurance policy and the level of influence 
(power) they have in relation to the new policies.
For the development of the decision tool, these medical insurance representa-
tives were invited to participate in the workshop. In addition, academic policy 
influencers and public health experts participated in the presentations and 
discussions.
In the subsequent steps of piloting, validation, and full implantation (beyond 
the described workshop), a broader range of stakeholders has to be involved or 
managed to ensure that their interests are represented, and the decision principles 
are accepted by expanded stakeholders.
2.1.2 Adaptation of global format to the decision problem
As outlined in the introduction (see Sections 1.1 and 1.2), the national policies 
could benefit by improvements in the insurance coverage scheme for urban employ-
ees. To accommodate the comparison of alternative insurance policies a multicri-
teria decision tool was created to test how well each insurance option addressed 
national and provincial requirements.
For this, a set of requirements was identified through desk research and discus-
sion with policy-makers and academic health policy experts before the workshop by 
the core team, which led to the base set of evaluation criteria.
Figure 1. 
Process applied for adapting a previously developed MCDA tool and framework to the decision problem of 
developing new insurance policies in China.
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2.1.3 Proposed decision criteria
Preliminary criteria were identified in the five domains presented in Figure 2: (1) 
funding and finance, (2) access, (3) policy priority (access), (4) equity, and (5) likeli-
hood of change. Each of the domains contained two or three criteria as defined below 
with a total number of 11 criteria. Of the five domains, two ((2) access and (3) policy 
priority) were related to access. While more criteria had been considered, it was impor-
tant to manage the number of criteria. The relevance and feasibility of the proposed 
criteria was further challenged in the workshop by the participating stakeholders.
Under the domain of “funding and finance,” two criteria were proposed. The 
criterion “financial impact for insurance” should help to roughly estimate the finan-
cial risk of a potential future health policy on health-care expenditure to be covered 
by the insurance scheme in comparison to the current insurance expenditure. To 
estimate the impact of a future insurance model on overall extent of insurance 
expenditure would be available as funding for healthcare, a criterion “mobilization 
of funding for outpatient healthcare (HC)” was proposed.
To assess the impact of a future policy on overall “access” for patients to health-
care, three criteria were predefined. With the criterion “access to pharmaceuticals,” 
the impact of a new insurance model on patient access to ambulatory pharmaceuti-
cal therapies as compared to the current system should be assessed. As most of 
the ambulatory care is made up by pharmaceuticals, which currently are to a large 
extent paid by the patients out-of-pocket, improvement in this area would be a 
major achievement. To compare the expected impact of the new model on overall 
coverage for healthcare in the outpatient setting, the second criterion “outpatient 
coverage” was suggested. The third criterion “economic burden for patients” was 
introduced to assess the impact of the potential future health policy on the patients’ 
finances in comparison to the current system.
A separate domain named “access/policy priority” was put forward for discus-
sion in the workshop to emphasize the need of meeting the policy priorities set by 
the national government policy. The first priority to be addressed is “timely inter-
ventions” (care when it is needed) to assess the impact of the future model on time 
to care (initiated by patient, family member, or insurance model). The intent here 
is to decrease the hurdles or improve the motivation for searching for healthcare 
early in the disease process instead of waiting until reaching more severe disease 
states before seeking care. The second criterion in this domain, “primary care 
utilization” is meant to help determine the impact of the future policy on the use of 
primary care in comparison to the current system. The policy objective emphasized 
Figure 2. 
Five domains for assessing the impact of insurance policy options on the intended outcomes of the policy changes.
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by this criterion is to shift care more toward the primary care level with much lower 
hurdles for patients as opposed to the current practice of accessing care mostly 
through specialized hospital services.
Two criteria were attributed to the domain of “equity.” “Solidarity for outpatient 
HC” appeared an important criterion to compare the impact of the new policy 
system on the solidarity principle. Full solidarity would mean equal health-care cost 
to everybody independent from personal health status. Furthermore, the impact of 
the future insurance model on health-care equity as compared to the current situa-
tion should be captured under the criterion of “equity.” This could potentially also 
imply higher contributions for people with higher income.
An important aspect to look at is the feasibility of introducing a new insurance 
policy model. This was to be addressed by the domain of “likelihood of change.” The 
criterion “ease of transition,” required an estimate of the smoothness of transition-
ing from the current to the future model. A specific criterion “acceptability to 
stakeholders” was proposed to account for the resistance of key stakeholders toward 
changing from the current to the potential future system. The final domains and 
their related criteria are presented in Table 2.
2.1.4 Proposed scoring for the decision criteria
For each of the proposed criteria, a scoring scale was developed. The scoring 
definitions were mostly qualitative assessments and nonlinear. For example, the 
possible outcomes and related scores for “financial risk for insurance” were high 
risk of nonmanageable cost increase (exclusion), increased but manageable cost increase 
(25%), minimal cost increase expected (50%), same cost as current (75%), decreased 
cost to insurance expected (100%). In this example, exclusion means that an insur-
ance option would be immediately excluded which can, with reasonable certainty, 
be expected to lead to massive financial impact to a degree which may bankrupt 
the insurance. Another example of a proposed scoring is the criterion of “equity” 
with the possible outcomes of “high degree of HC differences within population” 
(0%), “limited improvement of HC equity” (25%), “(limited) improvement of HC 
equity” (50%), “HC equity is mostly satisfied” (75%), “HC is the same for every-
body” (100%).
Except for the score “exclusion,” all scores are expressed in percentages. This 
method provides for a normalization within the scoring system even if each score 
does not have the same number of scoring levels. This also allows for differentiation 
between the importance of the possible outcomes. The final score for each criterion 
will be calculated from the score (in percentage) and the maximum score achiev-
able by this criterion (described in Section 2.3).
2.2 Interactive stakeholder workshop
The interactive stakeholder workshop took place in Beijing, China, on 
September 14, 2018 under the leadership of Professor Shanlian Hu (Fudan 
University). The agenda started with introductory presentations on the policy 
changes which triggered the initiative. The view on the initiative from different 
perspectives (e.g., academic, policy, industry) was presented through a moder-
ated discussion of participants’ expectations and viewpoints on upcoming 
changes and the expected improvements in health insurance schemes. This was 
followed by an interactive component to develop a common general decision 
model following a validated MCDA calculation model and process for local adap-
tation [30, 35]. This portion of the workshop was moderated by two international 
health-policy advisors.
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Gaps in current health-care coverage and insurance 
systems
Expected improvements with a future 
insurance policy
Equity
• There is a high difference of levels of care between the 
provinces (cross-provincial inequity)
Funding/finance
• Ineffectiveness of personal savings accounts
• Wasteful spending behaviors for resources in personal 
savings
• Nontargeted and no purposive dissipation of funds due  
to individual administration of personal savings accounts
Access
• Rudimentary organization of outpatient care
• Coverage breadth is very narrow/limited
Policy priorities
• Lack of a coordinated management system for policy 
changes
• Overuse of tertiary hospitals
• Current focus on procuring what is demanded for
Equity
• Improve the use of effective therapies
• Achieve equality in access
Funding/finance
• Better allocate funding to more effec-
tive therapies
Access
• Expanded coverage in more disease 
areas
• Doctors have more choice for 
prescribing the best suited therapies 
for each patient
Policy priorities
• More holistic and integrated view on 
health-care decisions
• Striking the balance between good 
care and financial feasibility
• Supplying effective therapies needed 
by the patients
General
• Allow for more flexibility by having a 
solid decision system and guidance
• Allow for pilot schemes in hospitals 
and pharmacies
Table 1. 
Summary of current insurance system shortcomings and expected improvements for future policies.
Because the workshop facilitators spoke English, the entire workshop was sup-
ported by simultaneous translation to ensure involvement, understanding, and con-
tribution of all participants. All materials were made available in the both languages.
The flow of the interactive part of the workshop is depicted in Figure 3.
2.2.1 Discussion change objectives
Each insurance representative had the opportunity to address shortcomings of 
the current system and their expectations for an improved insurance scheme. The 
key statements resulting from this discussion are summarized in Table 1. These 
shortcomings and expectations were well aligned with those proposed by the core 
team during the workshop preparation. Overall, there was high concordance among 
the participants.
Finally, participants shared a common voice that the workshop would yield a 
tool to choose the most rational insurance system to meet the needs of their provin-
cial environments, while still maintaining national consistency.
Figure 3. 
Six-step process for developing the MCDA tool in a workshop with key decision-makers for prioritizing 
insurance policy options in China.
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2.2.2 Discussion and refinement of criteria
Each domain and their related preliminary criteria were presented and dis-
cussed with workshop participants. The participants confirmed the relevance of all 
proposed domains and criteria except under the domain funding and finance. The 
criterion “mobilization of funding for outpatient HC” was dropped as participants 
stated that concept was covered by the “financial impact for insurance” criterion. 
Thus, these 2 criteria were merged into one and that resulted in 10 criteria across 5 
domains as listed in Table 2.
2.2.3 Discussion and refinement of scoring
The proposed scoring for all criteria was reviewed and general agreement was 
reached that the scoring should systematically apply the same number, levels, and 
results of possible scores. A consistent five-level scoring for each criterion was 
developed, whereby the first criterion would always result in exclusion of that 
insurance option. The scoring is defined in Table 3.
2.3 Model construction
A multicriteria decision analysis was demonstrated in Excel (Microsoft™). 
Although the model was programmed before the workshop based on the predefined 
Domain Criterion Definition
Funding and 
finance
Financial impact and 
funding for insurance
To estimate the financial impact of a potential future 
health policy on health-care expenditure to be covered 
by the insurance scheme in comparison to the current 
expenditure
Access Access to pharmaceuticals To estimate the impact of a new insurance model on 
patient access to ambulatory pharmaceutical therapies as 
compared to the current system
Coverage for outpatient 
HC
To compare the expected impact of the new model on 
overall coverage for ambulatory care
Affordability: economic 
burden for patients
To assess the financial impact on out-of-pocket cost for 
the patients or family
Policy priority Timely interventions To assess the impact of the future model on time to care 
(initiated by patient, family member, or insurance model)
Primary care utilization To estimate the impact of the future policy on the use of 
primary care in comparison to the current system
Equity Solidarity for outpatient 
HC
To compare the impact of the new policy system on the 
solidarity principle. Full solidarity = equal HC cost to 
everybody independent from personal health status
Equity To estimate the impact of the future insurance model 
on health-care (HC) equity as compared to the current 
situation
Likelihood of 
change
Ease of transition To estimate the smoothness of transitioning from the 
current to the future model
Acceptability to 
stakeholders
To estimate the resistance of key stakeholders toward 
changing from the current to the potential future system
Table 2. 
Domains and criteria with definitions as determined in the workshop.
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Table 3. 
Outcomes definitions and scoring for each decision criterion.
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domains, criteria, and scoring, there was continuous adaptation throughout the 
workshop to reflect the input of the participants. The final model integrated all 
results from the workshop.
Once agreement had been reached on the domains, criteria, and scoring func-
tions, the participants were guided through the process of ranking the criteria and 
subsequently weighing them for their relative importance.
This involved an anonymous voting with an audience response system (Ombea® 
with OMBEA ResponsePad™) for defining the decision priorities among the list of 
10 criteria (step 4 in Figure 3) and the relative importance of each of the criteria 
in the overall decision (step 5 in Figure 3) following the modified simple multiat-
tribute rating technique (SMART) method for ranking and swing weighing of the 
criteria [29]. For each vote, the result was computed as a median value. The result-
ing model was tested and reviewed using two test cases (step 6).
3. Testing the model
The first step in validating a decision model is testing the model with either 
known or extreme alternatives. During the workshop, there was limited time 
for testing; therefore, we will present two high-level insurance policy options to 
compare using the resulting model from the workshop.
3.1 Potential insurance scheme options
A concern raised during the introduction was that the insurance funds allocated 
to medical savings accounts (MSAs) are not used efficiently. Therefore, a key com-
ponent of health-care reform should include a more effective use of MSA funding.
The goals of a future reform would be to (1) increase the population solidarity 
and foster a more rational use of medical insurance premiums both from the per-
spective of the employee and the employer and thus (2) increase the efficiency of 
how the funds are utilized. In addition, the new policies should support key govern-
ment (national) health-care policy priorities such as (3) a shift health-care utiliza-
tion from tertiary to primary care services, and thus (4) incentivize earlier use of 
health-care services instead of delaying until more expensive inpatient services are 
required (timely interventions).
3.1.1 Insurance model option 1
The scope of payment for personal MSAs would be expanded to include addi-
tional services such as deductible (user fees) of hospitalization medical expenses, 
or for the medical expenses of other family members, paying the premiums of 
commercial medical insurance participation. Thus, insured employees would have 
more options for MSA spending and would still make individual decisions on when 
and how the money would be spent. This option would not provide an incentive to 
increase the use of outpatient care.
3.1.2 Insurance model option 2
A pooled outpatient funding system for the urban employees’ medical insur-
ance would be established, similar to how current inpatient service is funded. This 
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would create a gradual transition of payments into the coordinated population fund 
instead of the MSA and ultimately absorb the remaining funds in current MSAs. 
In this option, the decision on funding allocation would be made by the insurance 
authority or government across the entire insured population for both outpatient 
and inpatient care. Proactive funding of outpatient care would be intended to 
decrease inpatient care down the road.
3.2 Comparison of options
Four members of the project team and two additional Chinese health-care 
experts used the MCDA model to independently rate the two insurance policy 
options. Their answers were evaluated using the following rules:
a. If three or four of the raters answered identically, this was taken as the result for 
that attribute;
b. If the answers were distributed, the median result was used;
c. If the median was between two scores, the answers from the Chinese respond-
ents were given a higher weight;
d. If the result was between two scores, the more conservative response was chosen.
Following this approach, insurance option 2 was rated with a total of 78.0 points 
as the superior policy as compared to insurance option 1 with a total of 53.95 points. 
The detailed results are shown in Table 4. Insurance option 1 scored better for 
the attributes relating to “financial impact and funding for the insurance,” “access 
to pharmaceuticals,” coverage for outpatient healthcare, “affordability/economic 
burden to patients,” “timely interventions,” “primary care utilization,” “solidarity,” 
and “equity.” In the final two attributes “ease of transition” and “acceptability to 
stakeholders,” insurance option 1 was rated higher.
This example shows that there is a trade-off in any decision-making process—in 
this case between the domain “likelihood of change” where option 1 scored higher 
and for the other four domains, where option 2 scored higher. The model high-
lighted these trade-offs and made them more transparent. Once policy-makers 
agree on their final decisions, they are also more aware of what resistance may be 
expected and therefore may be better prepared to consider preventive measures to 
minimize such resistance.
3.3 Model observations
The intention of model testing was to understand (A) ease of use of the model 
for those using the model and (B) to see how consistent the answers are between 
different users.
To answer the first question, the users were specifically asked about their experi-
ence. The model was rated to be very easy (1) or easy (2) and neutral by two raters.
The interrater consistency varied depending on both the attributes and the 
insurance option. For most questions, there was a clear preference for one score. 
The highest response variability was observed for option 1 in relation to “financial 
impact and funding for insurance,” “primary care utilization,” “ease of transition,” 
and “acceptability to stakeholders.” The responses for option 2 had less variability.
In order to improve the interrater variability, two improvements were sug-
gested: (1) provide the raters with a more detailed description of the meaning of 
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an attribute and a score and (2) provide more a more detailed description of the 
two insurance models. An additional step of deliberation where a discussion could 
be led between the raters could give the rational for their individual ratings and 
consensus could be developed in the process. The latter approach would help to 
Table 4. 
Scoring of option 1 and option 2 in the MCDA model for the comparison of insurance models in China as rated 
by six test persons (four Chinese, two international).
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improve the cross-rater understanding as a part of the implementation and training 
process and enhance the consistent use of the model over time.
Two raters proposed to reduce the numbers of criteria for some of the options, 
because it may be difficult to determine the exact response if the gradual differences 
between the possible answers become too small.
We would propose when applying this model to a decision problem the interra-
ter variability should be monitored throughout the introduction phases. The results 
of these evaluations will help to improve the model over time.
4. Implementation process
Before releasing the model to provincial insurers, further pilot testing would be 
recommended. Ideally, a selected group of insurance experts would be asked to use 
the model in the assessment of their own insurance options and, in parallel, the two 
“standard” options as described above.
After the evaluation, the pilot users should be interviewed for their experience 
in the process and suggestions for improvement. This feedback could be used for 
building a next version tool, which could then be presented to the State Medical 
Insurance Bureau and released to a broader user group. In addition, guidance and 
training material should be developed to support interrater consistency in the 
application of the model. Dissemination could happen via various channels such as 
the State Medical Insurance Bureau or presentations and workshops at provincial or 
national conferences where insurance policy experts come together.
As mentioned above, the use of the model should be accompanied by an ongoing 
collection for user feedback (e.g., in an online survey format) and regular revision 
of the tool for further adaptation to new application requirements.
5. Discussion
5.1 Transferability within China
At the end of the first workshop, participants found high value in the MCDA 
approach toward building a criteria-based decision tool. In particular, they appreci-
ated the experience with the MCDA methodological approach which can be applied 
to decisions in technology assessment based on predefined requirements.
Yu et al. warned in a recent publication that “if supply-induced demand is not 
effectively controlled, a universal and uniform social health insurance may be more 
harmful than beneficial in China” [36]. By substituting the existing fee-for-service 
design with bundled provider payment policies, there can be more integrated 
approaches for smaller population groups that exist in China [37]. However, this is 
only possible, if allocation of funds for outpatient services is made by health-care 
decision-makers, guided by considerations of equity, access, and efficiency in 
public healthcare. Tools such as MCDA will improve transparency and consistency 
in health-care decision-making. Although the decision on the future UEBMI policy 
will be made on a provincial level, the evaluation tool will assist the decision-mak-
ers to go through a set of rational decision considerations (criteria) before selecting 
the most appropriate option. A consensus process, validated through a pilot testing 
phase, will provide a high level of legitimacy to the decision-making process.
UEBMI is the insurance system for urban employees. The other insurance 
options for urban residents (URBMI) or for rural citizens (NRCMS) could use 
similar tools for further developing their insurance options or to design a merged 
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insurance policy [38]. However, it should be noted that the three systems vary in 
terms of financing mechanisms, funding extent, and coverage policies and would 
require a full adaptation of the model. In addition, the stakeholders involved in 
the process might differ. For example, consumers or patients could be included as 
important stakeholders, because URBMI and NRCMS are voluntary systems and 
not mandatory by employment.
The described methodology could also be transferable to other types of decisions 
in China, such as which products should be listed or reimbursed, or which of the 
available alternatives should be purchased [30]. Such an application is presented in 
another chapter of this book at the example of purchasing off-patent pharmaceu-
ticals in hospitals in Thailand [39]. However, successful adaptation of the meth-
odology for each new type of application requires a thorough process described in 
Figure 1 of this report, including preparation, involvement of the decision stake-
holders, and phased implementation [33].
5.2 Country transferability
Many countries moving toward Universal Healthcare Coverage are building up 
their health-care systems and coverage policies. They will face similar decisions 
throughout this process. Although the instrument described here has been devel-
oped for the needs of the Chinese stakeholders in the context of the current insur-
ance policies, the process and the principles can be transferred to other countries. 
This structured and transparent approach for planning and implementation can 
provide learnings for improvement of health-care insurance policies.
5.3 Key learnings, challenges, and limitations
By using a structured and previously validated process for developing a decision 
support tool [33], we were able to work with key stakeholders from several prov-
inces in China during a 1-day workshop to apply the tool to a decision problem. The 
resulting MCDA spreadsheet model can be used by UEBMI insurance policy-makers 
in the provinces of China to compare new options of insurance policies.
A few key components in the process are essential for successful implementation. 
The most important is the engagement of the stakeholders impacted by the decision. 
Through the engagement of all stakeholders, a variety of factors can be considered 
and an open exchange is possible through a workshop format to incorporate all 
perspectives [40]. In addition, stakeholders, who are part of the “inner circle,” or the 
guiding coalition, can further to convey the momentum for change. This becomes of 
utmost importance once full implementation is realized [37, 40, 41]. In our example, 
the decision to limit the stakeholders to insurance experts and academic health 
policy leaders was purposeful to reflect the current decision-makers. However, a 
broader range of stakeholders may be involved in the testing phase of individuals’ 
provinces or countries.
Another key success factor is to clearly define the decision problem at the outset 
of the stakeholder collaboration. If there is a general agreement on the objective of 
the new policy, and on the criteria, which help to measure whether the objectives 
can be achieved, the MCDA tool offers an opportunity for increasing transparency 
of the decision process. Increased transparency may also contribute to a higher trust 
in the policies by the public in China [42].
The participants in the workshop cautioned that it may be necessary to adapt such 
a model in their respective provinces to address provincial health-care priorities, 
which may differ from province to province. A practical implication was use of the 
domains and criteria as a checklist for the design of new insurance policy options.
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Finally, for the long-term success of any future policy change, measurement of 
outcomes is important. The criteria used in the selection process could become key 
performance indicators around population health and economics as used in other 
evaluations [2, 5, 43].
Some limitations or pitfalls of using MCDA as a decision support tool need to 
be considered. First, there is a risk of bias in the MCDA when the criteria overlap 
and therefore overemphasize certain aspects of the evaluation. In our example, 
the participants felt this to be the case with the two finance-related criteria which 
were originally proposed. They, therefore, decided to merge the two criteria into 
one. Second, the ranking and weighing methodologies can have a high impact on 
the “resolution” capability of the decision support tool. In this chapter, we have 
used a modified SMART approach to MCDA which has been recognized broadly 
as practicable [23, 39]. It should also be emphasized that decision-makers may be 
tempted to use the summary score as “the decision argument.” Instead, decision-
makers should deliberate and compare the entire rating profile to confirm, that 
the instrument and the summary score have validity in the specific comparison. 
This will allow a more differentiated argumentation and documentation why 
a specific decision has been taken and which preventive measures should be 
taken to overcome the areas of weaknesses of the chosen option, which are those 
criteria, where it scored low.
There are also a few limitations to our proposed process. In our workshop, 
only a limited number of stakeholders were represented. Future programs 
should aim to achieve a good balance between all relevant stakeholders to 
maintain an active dialog during the workshop and manage the number of 
participants to avoid limitation of discussion. Preparation through stakeholder 
research, including mapping and assessment of appointments, is important to 
strike this balance.
Another limitation was the need to work with translators during the entire 
process, which was due to the international composition of the project management 
and moderating team. To minimize the risk for misunderstanding, the workshop 
was simultaneously translated and all materials, including the model, were available 
in both English and Chinese language.
6. Conclusions
In this report, we have demonstrated how an internationally developed and 
validated process based on MCDA methods was adapted to decide which funding 
model should be selected for the future UEBMI insurance policy in the provinces 
of China. The processes included extensive stakeholder analysis and engagement as 
well as an interactive workshop for building consensus on objectives of the reforms, 
the criteria for success, and the measures for scoring such criteria.
The advantage of combining stakeholder driven cocreation with the principles 
of multicriteria decision analysis was to build a model with the input and final 
consensus of key stakeholders that still allows for local adaptation of criteria, 
weighing, and scoring. Using such a structured decision model fosters consistency 
and transparency across all decisions and allows for documentation of the decision 
process and evaluation of the impact.
We would like to end this report with a specific concluding comment of one 
of the workshop participants: “It is hard to predict the future; but using a rational 
method to approximate the future needs for insurance models will help me to 
convince my constituents.”
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